EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase
about
A multi-targeted approach to suppress tumor-promoting inflammationGrape seed proanthocyanidins inhibit melanoma cell invasiveness by reduction of PGE2 synthesis and reversal of epithelial-to-mesenchymal transition.Polyphenols and aging.Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signalingA novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon.Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.Green tea polyphenol tailors cell adhesivity of RGD displaying surfaces: multicomponent models monitored optically.Cancer chemoprevention by polyphenols and their potential application as nanomedicine.Green tea catechins: a fresh flavor to anticancer therapy.Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro.Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptorsMulberry fruit (Moris fructus) extracts induce human glioma cell death in vitro through ROS-dependent mitochondrial pathway and inhibits glioma tumor growth in vivo.Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion.Epigallocatechin Gallate Inhibits Mouse Mesenchymal Stem Cell Differentiation to Adipogenic Lineage.Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy.
P2860
Q28393278-7DF70D7E-B35D-4C4D-83E6-5F00E11FCCB2Q33955027-26174F42-C37A-4C16-B13D-438AD09FD28EQ33957220-F9999FCB-5772-46AB-BB38-ED9433CD0127Q34055550-6671D7E4-810C-4F29-A84F-F37DCA59A194Q34666257-FD688849-064F-400E-BD59-4F83FF88E1C8Q35889665-5D0742EC-1DE7-44A4-99ED-6A3EFD64BF84Q36825244-A6E03F1A-6027-4000-9164-E9EB2E3E1CCEQ36946657-F88F5FB2-B1AC-429E-968B-950D75F842D7Q37635391-48594336-5E0F-4362-8EF6-38EE2B69CC19Q38093653-4D959398-F4EE-404E-9D5B-F36B806B838EQ38147993-D1A83248-364E-4DA6-840C-72EC5DC6E9E2Q38841650-FB158E25-2D6A-460F-BB87-25F7F2FEA79EQ38851914-3C27924B-51FB-471E-87B0-650F3B26BD51Q39562657-D6FCCF47-8D8C-467A-B720-01D8A5DB7174Q39640064-7D8E55D2-6804-4432-A573-646DF01170F6Q39720153-329DAB6D-5955-499C-A249-FF04F314CAE9Q39884097-C88A8BBC-01B6-4598-AF6B-388F04BFD4FCQ42453666-FDD38D3C-0D9C-487E-9849-88B431386CB2Q52597485-E1D77E4D-CFE4-4919-87E2-E51CCD736AF1
P2860
EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
EGCG inhibits mammary cancer c ...... synthase and guanylate cyclase
@en
type
label
EGCG inhibits mammary cancer c ...... synthase and guanylate cyclase
@en
prefLabel
EGCG inhibits mammary cancer c ...... synthase and guanylate cyclase
@en
P2093
P2860
P1476
EGCG inhibits mammary cancer c ...... synthase and guanylate cyclase
@en
P2093
Santosh K Katiyar
Thejass Punathil
Trygve O Tollefsbol
P2860
P304
P356
10.1016/J.BBRC.2008.07.157
P407
P577
2008-08-08T00:00:00Z